Crucially, biomarkers of systemic inflammation, including CRP, SIPS and mGPS, predict survival in patients with cancer treated with cytotoxic chemotherapy, targeted therapy or immune‐checkpoint inhibitors.12, 13, 14, 15. Here, CRP is linked to cancer.